0001209191-17-005642.txt : 20170126
0001209191-17-005642.hdr.sgml : 20170126
20170126080556
ACCESSION NUMBER: 0001209191-17-005642
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170125
FILED AS OF DATE: 20170126
DATE AS OF CHANGE: 20170126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAUWENBERGH GEERT
CENTRAL INDEX KEY: 0001285648
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 17548075
MAIL ADDRESS:
STREET 1: 1 STULTS DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-25
0
0001533040
RXi Pharmaceuticals Corp
RXII
0001285648
CAUWENBERGH GEERT
C/O RXI PHARMACEUTICALS CORPORATION
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
1
1
0
0
President & CEO
Common stock, $0.0001 par value
2017-01-25
4
P
0
300
0.69
A
62883
D
Common stock, $0.0001 par value
2017-01-25
4
P
0
9700
0.6968
A
72583
D
Common stock, $0.0001 par value
4500
I
By spouse
Common stock, $0.0001 par value
450
I
By son
Represents shares held by the Reporting Person's son. The Reporting Person disclaims beneficial ownership of such shares and this report shall
not constitute an admission of beneficial ownership.
Caitlin Kontulis, attorney-in-fact
2017-01-26